Browse Data and Analysis

There is no legal impediment to the use of biotechnology in El Salvador. Genetically engineered (GE) corn field trials were successfully completed.

Salvadoran restaurants and hotels continue to benefit from growth in the tourism sector, especially the business/convention and emerging surf sectors.

During 2019, the Salvadoran retail sector, valued at approximately $4.5 billion, continues to show positive signs of growth as supermarkets and discount stores have expanded operations.

Bosnia and Herzegovina (BiH) allows permitted import of genetically engineered (GE) products based on the 2009 Law on “Genetically Modified Organisms” (“GMOs”) and its pertaining bylaws.

Bosnia and Herzegovina (BiH) allows permitted import of genetically engineered (GE) products based on the 2009 Law on “Genetically Modified Organisms” (“GMOs”) and its pertaining bylaws.

Bosnia and Herzegovina (BiH) allows permitted import of genetically engineered (GE) products based on the 2009 Law on “Genetically Modified Organisms” (“GMOs”) and its pertaining bylaws.

After a five-year moratorium on genetically engineered (GE) products imposed with the 2004 Food Law, in 2009 Bosnia and Herzegovina (BiH) adopted the Law on “Genetically Modified Organisms” (“GMOs”).

Since the United States entered into the CAFTA-DR trade agreement, U.S. agricultural exports to the six CAFTA-DR countries have more than doubled.

Prolonged persistent heat and lack of precipitation for several months are seriously affecting corn, soybean, fruit and vegetable production in Bosnia and Herzegovina.

Central America and the Caribbean, with their close geographical and economic ties to the United States, have always been an important market for U.S. agricultural exports.

In 2008, El Salvador abolished the Planting Seed Law that required imported seeds to have a phytosanitary certificate with an additional declaration stating that the seeds did not contain GMOs.

El Salvador has no legal restriction on the use of agricultural biotechnology. However the country's biotech regulatory framework is still being developed.